Skip to main content
OpenTrials

Clinical trial condition

Leukemia, Myeloid

Explore clinical trials studying Leukemia, Myeloid. Study availability and eligibility vary by location and protocol.

3,108 public trials 620 recruiting studies
Refine in advanced search Browse all conditions

Leukemia, Myeloid trial results

Completed

Cyclosporine Eye Drops in Preventing Graft-Versus-Host Disease of the Eye in Patients Who Have Undergone Donor Stem Cell Transplant for Hematologic Cancer or Bone Marrow Failure Disorder

NCT00755040

Conditions
Blast Crisis, Blood Protein Disorders, Bone Marrow Diseases, +62 more
Locations
  • Stanford University Palo Alto, California, United States
  • Norwestern Memorial Hospital Chicago, Illinois, United States
  • Vanderbilt-Ingram Cancer Center Nashville, Tennessee, United States
  • M. D. Anderson Cancer Center Houston, Texas, United States
View Trial Details
Completed

A Study of Anagrelide Controlled Release (GALE-401) in Patients With High Platelet Counts Due to Bone Marrow Disorders

NCT02125318

Conditions
Blood Coagulation Disorders, Blood Platelet Disorders, Bone Marrow Diseases, +21 more
Locations
  • East Valley Hematology and Oncology Medical Group Burbank, California, United States
  • California Cancer Associates for Research & Excellence (cCARE) Encinitas, California, United States
  • California Cancer Associates for Research & Excellence (cCARE) Escondido, California, United States
  • California Cancer Associates For Research and Excellence Fresno, California, United States
View Trial Details
Completed

Efficacy and Safety of Panobinostat (LBH589) in Patients With Refractory de Novo or Secondary Acute Myelogenous Leukemia (AML)

NCT00880269

Conditions
Acute Myelogenous Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +6 more
Locations
  • University of Chicago Medical Center Dept. of U. of Chicago Hosp(3) Chicago, Illinois, United States
  • Nebraska Methodist Hospital Nebraska Methodist Hospital(2) Omaha, Nebraska, United States
  • North Shore University Hospital North Shore Univ Manhasset, New York, United States
  • Memorial Sloan Kettering Cancer Center Dept. of MSKCC (2) New York, United States
View all 40 locations
View Trial Details
Completed

Study of Treatment With Nilotinib in Adult Patients With Imatinib - Resistant or - Intolerant Chronic Myeloid Leukemia in Blast Crisis, Accelerated Phase or Chronic Phase

NCT00786812

Conditions
Bone Marrow Diseases, Chronic Disease, Chronic Myeloid Leukemia, +11 more
Locations
  • Novartis Investigative Site Belo Horizonte, Minas Gerais, Brazil
  • Novartis Investigative Site Curitiba, Paraná, Brazil
  • Novartis Investigative Site Rio de Janeiro, Brazil
  • Novartis Investigative Site Porto Alegre, Rio Grande do Sul, Brazil
View Trial Details
Completed

Alisertib for Acute Myeloid Leukemia

NCT01779843

Conditions
Acute Myelogenous Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Brigham and Women's Hospital Boston, Massachusetts, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
View Trial Details

Related conditions